组织切片市场规模、份额及成长分析（按产品、技术、材料类型、应用、最终用途和地区）－2025-2032 年产业预测

预计到 2023 年全球组织切片市场规模将达到 5.9486 亿美元，从 2024 年的 6.591 亿美元成长到 2032 年的 14.9718 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.8%。

组织切片市场对医疗保健和生命科学至关重要，促进了研究、诊断和治疗策略的进步。主要趋势表明，受癌症和神经系统疾病等慢性疾病盛行率上升的推动，经济成长强劲。组织切片可以详细检查薄组织样本，以支持组织病理学和分子生物学应用，这对于了解疾病进展和评估治疗效果至关重要。技术创新，尤其是自动化高通量系统的创新，正在提高准确性和效率，并最大限度地减少潜在的诊断错误。此外，随着个人化医疗和精准诊断的需求不断增长，精确的组织分析变得越来越重要，组织切片在製定客製化治疗计划和改善患者预后方面发挥着至关重要的作用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 专利分析

组织切片製备市场规模（依产品划分）

• 市场概览
• 装置
  • 旋转切片机
  • 滑动切片机
  • 超薄切片机
  • 低温恒温器
  • 其他的
• 配件和耗材
• 服务

组织切片市场规模（依技术划分）

• 市场概览
• 自动的
• 半自动
• 手动的

组织切片市场规模（依材料类型）

• 市场概览
• 聚甲醛
• OCT化合物
• 福马林
• 包埋介质

组织切片市场规模（按应用）

• 市场概览
• 诊断
• 调查

组织切片市场规模（依最终用途划分）

• 市场概览
• 医院
• 诊所
• 诊断实验室
• 研究中心

组织切片製备市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（USA）
• Leica Biosystems（USA）
• Sakura Finetek USA, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Merck KGaA（Germany）
• Roche Diagnostics（Switzerland）
• CellPath Ltd（UK）
• Gilson Incorporated（USA）
• RMC Boeckeler（USA）
• SLEE medical GmbH（Germany）
• MEDITE GmbH（Germany）
• Jinhua YIDI Medical Appliance Co., Ltd.（China）
• Diapath SpA（Italy）
• Hacker Instruments & Industries Inc.（USA）
• Bright Instrument Company td（UK）
• Boeckel+Co（GmbH+Co）KG（Germany）
• MICROS Produktions-und Handelsgesellschaft mbH（Austria）
• Nanolytik GmbH（Germany）
• Microservice Srl（Italy）
• Screen Holdings Co., Ltd.（Japan）

结论和建议

Global Tissue Sectioning Market size was valued at USD 594.86 million in 2023 and is poised to grow from USD 659.1 million in 2024 to USD 1497.18 million by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

The Tissue Sectioning Market is crucial to healthcare and life sciences, driving advancements in research, diagnostics, and treatment strategies. Key trends indicate robust growth, primarily fueled by the rising incidence of chronic diseases, including cancer and neurological disorders. Tissue sectioning enables detailed examination of thin tissue samples, supporting applications in histopathology and molecular biology, vital for understanding disease progression and evaluating treatment efficacy. Technological innovations, particularly in automated and high-throughput systems, are enhancing accuracy and efficiency, minimizing potential diagnostic errors. Moreover, as the demand for personalized medicine and precision diagnostics grows, the importance of precise tissue analysis escalates, solidifying tissue sectioning's integral role in developing tailored treatment plans and improving patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Sectioning market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Sectioning Market Segments Analysis

Global Tissue Sectioning Market is segmented by Product, Technology, Material Type, Application, End-Use and region. Based on Product, the market is segmented into Instruments, Accessories & Consumables and Services. Based on Technology, the market is segmented into Automatic, Semiautomatic and Manual. Based on Material Type, the market is segmented into Paraformaldehyde, OCT Compound, Formalin and Embedding Media. Based on Application, the market is segmented into Diagnosis and Research. Based on End-Use, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Sectioning Market

The increasing incidence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, has emerged as a major catalyst for the growth of the global tissue sectioning market. This essential technique in pathology and research plays a vital role in the diagnosis and comprehension of these medical conditions. With an aging global population and a corresponding rise in the prevalence of chronic diseases, there is a surging demand for tissue sectioning tools and services. Consequently, the tissue sectioning market is experiencing substantial growth, driven by the urgent need for precise diagnostic methods to address these health challenges.

Restraints in the Global Tissue Sectioning Market

The Global Tissue Sectioning market faces notable constraints primarily due to the high costs associated with advanced automated tissue sectioning equipment. This financial burden can deter smaller laboratories, clinics, and research institutions that operate on tight budgets from investing in such technology. The substantial initial expenses related to both the purchase and maintenance of these advanced systems can obstruct their widespread adoption, particularly in environments with limited financial resources. Consequently, the financial barriers presented by the pricing of tissue sectioning equipment may hinder technological advancements and limit access to quality tissue sectioning solutions in various healthcare and research settings.

Market Trends of the Global Tissue Sectioning Market

The Global Tissue Sectioning market is witnessing a transformative shift driven by the automation and digitization of tissue sectioning processes. Automated equipment, including advanced microtomes and cryostats, significantly enhances workflow efficiency and precision, thereby minimizing cross-contamination risks. This increase in automation is complemented by a notable trend towards digitizing tissue samples, fostering improved storage, analysis, and interoperability among pathology laboratories. The rise of digital pathology systems, integrated with sophisticated image analysis software, is making it easier for researchers and clinicians to access and interpret tissue data, ultimately propelling advancements in diagnostics and personalized medicine within a fast-evolving marketplace.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis

Global Tissue Sectioning Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
  • Rotary Microtome
  • Sliding Microtome
  • Ultramicrotome
  • Cryostat
  • Others
• Accessories & Consumables
• Services

Global Tissue Sectioning Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Automatic
• Semiautomatic
• Manual

Global Tissue Sectioning Market Size by Material Type & CAGR (2025-2032)

• Market Overview
• Paraformaldehyde
• OCT Compound
• Formalin
• Embedding Media

Global Tissue Sectioning Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnosis
• Research

Global Tissue Sectioning Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Laboratories
• Research Centers

Global Tissue Sectioning Market Size & CAGR (2025-2032)

• North America (Product, Technology, Material Type, Application, End-Use)
  • US
  • Canada
• Europe (Product, Technology, Material Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Material Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Material Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Material Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellPath Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilson Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RMC Boeckeler (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLEE medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jinhua YIDI Medical Appliance Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diapath S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hacker Instruments & Industries Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bright Instrument Company td (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boeckel + Co (GmbH + Co) KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICROS Produktions- und Handelsgesellschaft m.b.H (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanolytik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microservice S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Screen Holdings Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations